InfectoGnostics Research Campus Jena

Breaking New Ground in Infection Diagnostics

A reliable diagnosis is the precondition for the efficient and personalized treatment of infectious diseases. In addition to using non-invasive and thus more patient-friendly methods to identify bacteria, viruses or fungi in general, it is also important to detect antimicrobial resistances in order to safeguard the basis for correct antibiotic treatment decisions. Novel rapid tests could enable medical practicioners to identify types of pathogens and potential resistances very quickly. With its rapid and highly efficient diagnostic methods, InfectoGnostics plays a major role in fighting the growing global threat of antimicrobial resistances.

The InfectoGnostics Research Campus Jena is breaking new ground in the diagnosis of infectious diseases and infection research. Latest scientific findings from the areas of infection research, optics and photonics, molecular biology and microfluidics are being swiftly translated into application-oriented, analytical methods to support patients. In this way, the triad of technology, application and production is presenting mature solutions which enable timely and cost-effective point-of-care testing of infections in human medicine and test systems for animal diseases as well as making it possible to detect food-borne pathogens.

The research campus brings together scientists, physicians and industry representatives from around 20 contractual and organizational partner institutions. InfectoGnostics thus serves as an incubator for new ideas and methods which the companies involved can turn into mature products, thereby bringing real benefit to patients. The Centre for Applied Research (ZAF) in Jena is the hub of this interdisciplinary cooperation with over 1,000 square metres of laboratories and offices under one roof where researchers from different institutions meet and collaborate on a regular basis. The strategic partnership between science and industry is aimed at establishing a European centre for infection diagnostics in Jena, which will distinguish itself by providing excellent research and advanced training in synergy with basic research, application and translation.

Close-up of a pipetting procedure in a laboratory of the Research Campus Jena.

InfectoGnostics Research Campus

This flyer is about the InfectoGnostics Research Campus in Jena. It is one of nine inserts that complement the brochure entitled “Research Campus Funding Initiative”. The InfectoGnostics Research Campus aims to develop fast and cost-effective point-of-care diagnostics for infectious diseases in order to provide a sound basis for the right treatment decisions.

2 pages / flyer

Language: English

Partners in the Research Campus

  • Jena University of Applied Sciences (EAH)
  • Friedrich Schiller University Jena 
    • European Virus Bioinformatics Center (EVBC)
    • Institute of Physical Chemistry
    • Institute of Microbiology
    • Institute of Applied Physics
  • Jena University Hospital
    • Center for Sepsis Control and Care (CSCC) Integrated Research and Treatment Center
    • Center for Infectious Diseases and Infection Control
    • Institute of Clinical Chemistry and Laboratory Diagnostics
    • Institute for Biochemistry I
    • Institute of Medical Microbiology
    • Institute of Virology and Antiviral Therapy
  • Fraunhofer Institute for Ceramic Technologies and Systems IKTS
  • Friedrich-Loeffler-Institut – Federal Research Institute for Animal Health
  • Leibniz Institute of Photonic Technology (IPHT)
  • Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute
  • Alere Technologies GmbH
  • Analytik Jena AG
  • Biophotonics Diagnostics GmbH
  • Blink AG
  • Cetoni GmbH
  • CiS - Forschungsinstitut für Mikrosensorik GmbH
  • GWA – Gesellschaft für Wasser- und Abwasserservice GmbH
  • OncGnostics GmbH
  • Q.Instruments GmbH
  • R-Biopharm AG
  • SmartDyeLivery GmbH
  • Senova GmbH
  • X-Case GmbH